[1]
Lemoine, L.A. and Segarra-Newnham, M. 2019. Evaluation of outcomes of 8-week therapy with ledipasvir/sofosbuvir or glecaprevir/pibrentasvir in veterans with hepatitis C infection. Annals of Clinical Gastroenterology and Hepatology. 3, 1 (Nov. 2019), 027–030. DOI:https://doi.org/10.29328/journal.acgh.1001011 .